SDEV — Stablecoin Development Share News
0.000.00%
Last trade - 00:00Brief: Phaseone Health And Novabay Pharmaceuticals To Expand Commercial And Collaborative Strategies For The Wound Care Market
Brief: Novabay Pharmaceuticals Files For Common Stock Offering Of Up To 327,860 Shares
Brief: NovaBay Pharmaceuticals Inc Files Prospectus Relates To Resale, From Time To Time, By Selling Stockholders Of Up To 1.5 Million Shares Of Common Stock - Filing
Brief: NovaBay Pharmaceuticals Announces 1-For-35 Reverse Stock Split
Brief: Novabay Pharmaceuticals Reports Third Quarter 2022 Financial Results
Brief: Novabay Pharma Receives NYSE American Notice Regarding Low Share Price
Brief: NovaBay Pharma CEO Issues Letter To Stockholders
Brief: Novabay Pharmaceuticals Enters Into Agreements For A Private Placement And Warrant Reprice Transactions To Raise Up To $5.3 Million
U.S. RESEARCH ROUNDUP- Cooper Companies, Intuit, Nordson Corp
Brief: NovaBay Pharmaceuticals Reports Second Quarter 2022 Financial Results
Brief: NovaBay Pharmaceuticals’ Dermadoctor Products Now Available At Target.com And Urbanoutfitters.com
Brief: Novabay Pharmaceuticals Inc - Announces Record Sales Of Avenova-Branded Products During Amazon's Prime Day Event
Brief: Novabay Pharmaceuticals Expands Top-Selling Dermadoctor Kakadu C And Calm Cool + Corrected Collections With New Anti-Aging Formulations
Brief: Novabay Pharmaceuticals CEO Issues Letter To Stockholders
Brief: Novabay Pharmaceuticals Engages Leading Chinese Marketing Firm To Drive Consumer Sales Of Dermadoctor Skincare Products In China
Brief: Novabay Pharmaceuticals Inc - Files For Offering Of 37.5 Million Shares Of Common Stock By Selling Shareholders - SEC Filing
Brief: Novabay Pharmaceuticals Announces Changes To Its Board Of Directors
Brief: NovaBay Pharmaceuticals To Donate 2.5 Million KN95 Masks
Brief: Novabay Pharmaceuticals Expands Its Eyecare Product Portfolio